Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CBFF093C.svg?ark=w1%2F20260515%2FCBFF093C)](https://nobleid.org/work/w1/20260515/CBFF093C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors